• 1
    Hawkins PN. Hereditary systemic amyloidosis with renal involvement. J Nephrol 2003; 16: 443448.
  • 2
    Benson MD, Liepnieks JJ, Yazaki M et al. A new human hereditary amyloidosis: The result of a stop-codon mutation in the apolipoprotein AII gene. Genomics 2001; 72: 272277.
  • 3
    Kallinich T, Briese S, Roesler J et al. Two familial cases with tumor necrosis factor receptor-associated periodic syndrome caused by a non-cysteine mutation (T50M) in the TNFRSF1A gene associated with severe multiorganic amyloidosis. J Rheumatol 2004; 31: 25192522.
  • 4
    Uemichi T, Liepnieks JJ, Benson MD. Hereditary renal amyloidosis with a novel variant fibrinogen. J Clin Invest 1994; 93: 731736.
  • 5
    Lachmann HJ, Booth DR, Booth SE et al. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med 2002; 346: 17861791.
  • 6
    Uemichi T, Liepnieks JJ, Yamada T et al. A frame shift mutation in the fibrinogen Aα-chain gene in a kindred with renal amyloidosis. Blood 1996; 87: 41974203.
  • 7
    Hamidi Asl L, Liepnieks JJ, Uemichi T et al. Renal amyloidosis with a frame shift mutation in fibrinogen Aα-chain gene producing a novel amyloid protein. Blood 1997; 90: 47994805.
  • 8
    Uemichi T, Liepnieks JJ, Gertz MA, Benson MD. Fibrinogen Aα chain Leu554: An African-American kindred with late onset renal amyloidosis. Amyloid 1998; 5: 188192.
  • 9
    Hamidi Asl L, Fournier V, Billerey C et al. Fibrinogen Aα-chain mutation (Arg554Leu) associated with hereditary renal amyloidosis in a French family. Amyloid 1998; 5: 279284.
  • 10
    Herlenius G, Wilczek HE, Larsson M et al. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: Results from the familial amyloidotic polyneuropathy world transplant registry. Transplantation 2004; 77: 6471.
  • 11
    Suhr OB. Impact of liver transplantation on familial amyloidotic polyneuropathy (FAP) patients’ symptoms and complications. Amyloid 2003; 10(Suppl 1): 7783.
  • 12
    Montecinos HA, Richter H, Caprile T, Rodriguez EM. Synthesis of transthyretin by the ependymal cells of the subcommissural organ. Cell Tissue Res 2005; 320: 487499.
  • 13
    Ando Y, Terazaki H, Nakamura M et al. A different amyloid formation mechanism: De novo oculolepromeningeal amyloid deposits after liver transplantation. Transplantation 2004; 77: 345349.
  • 14
    Stangou AJ, Hawkins PN, Heaton ND et al. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: Implication for amyloid fibrillogenesis. Transplantation 1998; 66: 229233.
  • 15
    Gillmore JD, Stangou AJ, Tennent GA et al. Clinical and biochemical outcome of hepatorenal transplantation for hereditary systemic amyloidosis associated with apolipoprotein AI Gly26Arg. Transplantation 2001; 71: 986992.
  • 16
    Calandra S, Tarugi P. Synthesis and secretion of apolipoprotein A-I. Biochem Soc Trans 1993; 21: 493499.
  • 17
    Gillmore JD, Booth DR, Rela M et al. Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen α chain variant in an English family. Q J Med 2000; 93: 269275.
  • 18
    Zeldenrust S, Gertz M, Uemichi T et al. Orthotopic liver transplantation for hereditary fibrinogen amyloidosis. Transplantation 2003; 75: 560561.
  • 19
    Furtado AJ. Domino liver transplantation using FAP grafts. HUC experience-hopes and realities. Amyloid 2003; 10(Suppl 1): 8487.
  • 20
    Stangou AJ, Heaton ND, Hawkins PN. Transmission of systemic transthyretin amyloidosis by means of domino liver transplantation. N Engl J Med 2005; 352: 2356.